CyberArk, FireEye Q4 Sales Expected To Brake; But Stocks Rebound
CyberArk Software ( CYBR ) and FireEye ( FEYE ) stocks lent themselves to a security recovery Wednesday, both climbing ahead of their late-Thursday quarterly earnings reports after a four-day downtrend pounded IBD’s Computer Software-Security industry group. The 26-company group rose 1.7% Wednesday after hitting a one-year low on Tuesday, with shares of Qualys ( QLYS ), Imperva ( IMPV ) and Proofpoint ( PFPT ) leading the way, up 15.2%, 6.3% and 5.6%, respectively. CyberArk stock rose 2.3%, while FireEye stock jumped 3.7%. Still, the Computer Software-Security group ranks a mere 176 out of 197 groups tracked by IBD. But CyberArk and FireEye are expected to report sales, for Q4, that will have decelerated for their third- and sixth-consecutive quarters, respectively. CyberArk EPS Seen Falling For Q4, the consensus of 15 analysts polled by Thomson Reuters sees CyberArk reporting $43.9 million in sales and 20 cents earnings per share ex items, up 21% and down 5%, respectively. It would be the first time in six quarters that CyberArk’s earnings have fallen year over year. Three months ago, CyberArk guided to $43 million to $44 million in sales and 18-20 cents EPS minus items. CyberArk is expected to report a 49% year-over-year jump to $153.3 million in sales for the year. EPS is seen climbing 53% vs. 2014 to 81 cents. CyberArk previously guided to $152.3 million to $153.3 million in sales and 80-82 cents EPS minus items. Will FireEye’s Billings Recover? FireEye is expected to report $185.3 million in Q4 sales and a per-share loss ex items of 37 cents. On a year-over-year basis, sales would grow 30% and losses would shrink by a penny. In November, FireEye guided to $182 million to $190 million in sales, 36-38 cents per-share losses minus items and $240 million to $260 million in billings, which for the latter would be up 18% at the midpoint. For 2015, the consensus of 34 analysts polled by Thomson Reuters expects FireEye to report $623.4 million in sales, up 46%. Losses per share ex items of $1.62 are expected to lessen from $1.97 in 2014. The company previously guided to $620 million to $628 million in sales and losses per share ex items of $1.61 to $1.63. Billings guidance for $780 million to $800 million would be up 34% at the midpoint.